Patients with severe, persistent asthma (~4%-10% of all asthma cases) have the highest risk of morbidity and mortality. They contribute significantly to the economic burden of asthma and represent an unmet need in asthma therapy.
Effective treatments for common chronic respiratory conditions are available to alleviate symptoms, prevent disease progression, and improve quality of life; however, many patients attribute their shortness of breath and decreased ability to perform usual activities to the normal aging process and only seek treatment in urgent-care settings for acute exacerbations.
Each year, the Advisory Committee on Immunization Practices (ACIP) reviews the recommended adult (anyone over 18 years old) and children 18 years and younger, immunization schedule to ensure that the schedules reflects current recommendations for the licensed vaccines.
This activity will provide the participant with the latest up-to-date information for thyroid disease and review of treatment for both subclinical and overt disease. Discussion will include management of therapeutic options as well as counseling, screening, and monitoring the pregnant thyroid patient.
COPD is a common, preventable, and treatable disease characterized by progressive persistent airflow limitation. COPD is clearly a cause of morbidity and mortality and results in an ever-increasing economic and social burden.
Patients with asthma should gain knowledge, skills, and confidence to assume the major role in the day-to-day management of their disease. This activity will highlight specific patient education and health literacy tools, including the personalized asthma action plan, written in language that the patient can read and understand.
The clinical practice of medicine involves a continual balance of evidence-based information applied to clinically complex scenarios amongst the human factors of fears, preferences, results, and economics. This continuing education module focuses on the clinicians’ skills, resources, tools and approaches for more optimal choice, use, and thus better outcomes, involving inhaled medications.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death and 12th leading cause of morbidity in the United States. This activity will address the use of spirometry for diagnosis and treatment of COPD, explore the benefits of exercise and pulmonary rehabilitation, and identify treatment options for optimal patient outcomes.
Asthma is a chronic disease associated with inflammation in the airways. The inflammation is strongly linked with airway hyperresponsiveness and the typical asthma symptoms. Understanding the full spectrum of the pathology and the pathogenesis of asthma should be used for defining the treatment options.